Clinicopathologic features of early vs late recurrence of HR+,HER2- EBC
Dr. O’Shaughnessy elaborates on the spectrum of high-risk HER+,HER2- early breast cancer and discusses the clinicopathologic features associated with early and late recurrence.
Date of Last Review: Feburary 14, 2023
Document Number: VV-MED-135247
Clinicopathologic features of early vs late recurrence of HR+,HER2- EBC
is now playing
1:28
Are you satisfied with this content?